Cyclic peptide based angiogenic inhibitors.

基于环肽的血管生成抑制剂。

• 批准号: nhmrc : 1028509
• 负责人: Prof David Craik
• 金额: $ 25.09万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2014-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/cyclic-peptide-based-angiogenic-inhibitors/110641
• 关键词: Cyclic; peptide; based; angiogenic; inhibitors.

This project aims to develop a novel class of drugs with the potential to overcome the stability problems previously associated with protein-based drugs. We will develop novel molecules for the treatment of cancer and cardiovascular disease. This project has the potential to lead to major economic and social benefits to Australia via royalty returns from drug sales and reduced costs for health care for patients with these diseases.

该项目旨在开发一类新的药物，有可能克服以前与蛋白质药物相关的稳定性问题。我们将开发用于治疗癌症和心血管疾病的新分子。该项目有可能通过药品销售的特许权使用费回报和降低这些疾病患者的医疗保健成本，为澳大利亚带来重大的经济和社会效益。